Repaglinide Can Cause Hypoglycemia-Additional Note

The Medical Letter on Drugs and Therapeutics

FROM
ISSUE

1029

June 19, 1998

View Complete Issue Table of Contents 2019

Repaglinide Can Cause Hypoglycemia-Additional Note

View Complete Issue

Send Article Feedback

Med Lett Drugs Ther. 1998 Jun 19;40(1029):66

Disclosures

Objective(s)

SUMMARY: Several readers have pointed out that the conclusion of the Medical Letter article on repaglinide (vol. 40, page 56, May 22, 1998) can be interpreted to mean that the drug does not cause hypoglycemia. The incidence of hypoglycemia has been only slightly lower with repaglinide than with sulfonylureas.

The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.

This article has been freely provided.